Clarithromycin and omeprazole: As Helicobacter pylori eradication therapy in patients with H. pylori-associated gastric disorders

Drugs

Volumn 51, Issue 1, 1996, Pages 161-178

  Markham, Anthony ^a   McTavish, Donna ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; AMOXICILLIN; ANTIINFECTIVE AGENT; CLARITHROMYCIN; MACROLIDE; NITROIMIDAZOLE; OMEPRAZOLE;

ABDOMINAL PAIN; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; DIARRHEA; DRUG COST; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG TOLERABILITY; GRAM NEGATIVE INFECTION; HEADACHE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; NAUSEA; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; REVIEW; STOMACH DISEASE; TASTE DISORDER; VOMITING;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI; NEGIBACTERIA;

EID: 0030049710     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199651010-00010     Document Type: Review

References (67)

1. DeCross AJ, Marshall BJ. The role of Helicobacter pylori in acid-peptic disease. Am J Med Sci 1993 Dec; 306 (6): 381-92
2. Lee A. The microbiology and epidemiology of Helicobacter pylori infection. Scand J Gastroenterol 1994 Sep; 29 Suppl. 201: 2-6
3. Dixon MF. Pathophysiology of Helicobacter pylori infection. Scand J Gastroenterol 1994 Sep; 29 Suppl. 201: 7-11
4. Axon ATR. The role of omeprazole and antibiotic combinations in the eradication of Helicobacter pylori - an update. Scand J Gastroenterol 1994; 29 Suppl. 205: 31-7
5. Blaser MJ. Helicobacter pylori phenotypes associated with peptic ulceration. Scand J Gastroenterol 1994; 29 Suppl. 205: 1-5
6. Ernst PB, Jin Y, Reys VE, et al. The role of the local immune response in the pathogenesis of peptic ulcer formation. Scand J Gastroenterol 1994; 29 Suppl. 205: 24-8
7. Glupczynski Y. The diagnosis of Helicobacter pylori infection: a microbiologist's perspective. Rev Med Microbiol 1994; 5 (3): 199-208
8. Gustavson LE, Kaiser JF, Edmonds AL, et al. Effect of onieprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state. Antimicrob Agents Chemother 1995 Sep; 39(9): 2078-83
9. Fernandes PB, Hardy DJ, Comparative in vitro potencies of nine new macrolides. Drugs Exp Clin Res 1988; 14: 445-51
10. Cederbrant G, Kahlmeter G, Schalén C, et al. Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori. J Antimicrob Chemother 1994 Dec; 34: 1025-9
11. McTavish D, Buckley MM-T, Heel RC. Omeprazole: an updated review of its pharmacology and therapeutic use in acid-related disorders. Drugs 1991 July; 42 (1): 138-70
12. Wilde MI, McTavish D.. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders. Drugs 1994 Jul; 48: 91-132
13. Logan RPH, Walker MM, Misiewicz JJ, et al. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995; 36: 12-6
14. Graham DY, Genta R, Evans DG, et al. Migration of H. pylori from the antrum to the corpus in response to omeprazole is a myth [abstract no. 114]. Am J Gastroenterol 1995; 90: 1582
15. Danon SJ, O'Rourke JL, Lee A. The importance of local acid production on the distribution of Helicobacter spp. in the gastric mucosa. Acta Gastroenterol Belg 1993; 56 Suppl.: 109
16. Peters DH, Clissold SP. Clarithromycin: a review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. Drugs 1992 Jul; 44: 117-64
17. Bazzoli F, Gullini S, Zagari RM, et al. Effect of omeprazole and clarithromycin plus tinidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer [abstract]. Gut 1995; 37 Suppl. 1: A5
18. Goh KL, Parasakthi N, Peh SC, et al. Clarithromycin in the treatment and eradication of Helicobacter pylori in duodenal ulcer patients [abstract]. Gut 1995; 37 Suppl. 1: 97
19. Jaup BH, Norrby A. Low dose short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am J Gastroenterol 1994; 90 (6): 943-5
20. Kadayifçi A, Simsek H, Arslan M, et al. Low dose clarithromycin plus omeprazole eradicates Helicobacter pylori in duodenal ulcer disease. Am J Gastroenterol 1995 Mar; 90: 519-20
21. Labenz J, Stolte M, Domian C. High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease. Digestion 1995 Jan-Feb; 56: 14-20
22. Labenz J, Stolte M, Rühl GH, et al. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995 Jan; 7: 9-11
23. Logan RPH, Bardhan KD, Celestin LR, et al. Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: a randomized double-blind, multi-centre trial of omeprazole with or without clarithromycin. Aliment Pharmacol Ther 1995; 9: 417-23
24. Peterson WL, Graham DY, Marshall B, et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol 1993 Nov; 88: 1860-4
25. Burette A, Glupczynski Y, DePrez C, et al. Omeprazole alone or in combination with clarithromycin for eradication of Helicobacter pylori: results of a randomized double-blind controlled study [abstract]. Gastroenterology 1993 Apr; 104 Suppl.: A49
26. Greaves RG, Cayla R, Mendelson MG, et al. Omeprazole versus clarithromycin and omeprazole for eradication of H. pylori infection [abstract]. Gastroenterology 1994 Apr; 106 Suppl.: 84
27. Hunt R, Schwartz H, Fitch D, et al. Dual therapy of clarithromycin (CL) and omeprazole (OM) for treatment of patients with duodenal ulcers (DU) associated with H. pylori (HP) infection [abstract]. Gut 1995; 37 Suppl. 1: 5
28. Deltenre M, De Koster E, Van Gossum M, et al. Omeprazole based therapies for eradication of Helicobacter pylori [abstract]. Gut 1995; 37 Suppl. 1: 90
29. Gurbuz AK, Giardiello FM, Dagalp K, et al. Clarithromycin and omeprazole for Helicobacter pylori gastritis: an unsatisfactory regimen [abstract]. Gastroenterology 1994 Apr; 106 Suppl.: A85
30. Logan RPH, Gummett PA, Schaufelberger HD, et al. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994 Mar; 35: 323-6
31. Burette A, Glupczynski Y, Deprez C, et al. Omeprazole + amoxicillin + clarithromycin therapy for H. pylori infection [abstract]. Gut 1995; 37 Suppl. 1: A89
32. Jonas C, De Koster E, Nyst JF, et al. Helicobacter pylori treatment: an evaluation of ten days omeprazole-bismuth-clarithromycin [abstract]. Gastroenterology 1993 Apr; 104 (4): A112
33. Moayyedi P, Tompkins DS, Axon ATR. Efficacy often days of clarithromycin, amoxycillin and omeprazole in eradicating Helicobacter pylori infection [abstract]. Gut 1995; 37 Suppl. 1: 44
34. Moayyedi P, Sahay P, Tompkins DS, et al. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7: 835-40
35. Powell KU, Bell GD, Bowden AF, et al. An effective one-week Helicobticter pylori eradication therapy using omeprazole, clarithromycin and metronidazole. Br J Clin Res 1995; 6: 85-90
36. Trespi E, Villani L, Broglia F, et al. High efficacy of a clarithromycin-amoxycillin-omeprazole association for H. pylori eradication and treatment of ulcer-like or reflux-like dyspeptic symptoms [abstract]. Gut 1995; 37 Suppl. 1: 87
37. Yousfi MM, El-Zimaity HMT, Al-Assi MT, et al. Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1995 Apr; 9: 209-12
38. Katelaris PH, Patchett SE, Zhang ZW, et al. A randomized prospective comparison of clarithromycin versus amoxycillin in combination with omeprazole for eradication of Helicobacter pylori. Aliment Pharmacol Ther 1995 Apr; 9: 205-8
39. Neri M, Suzi D, Laterza F, et al. Omeprazole and clarithromycin vs. omeprazole and amoxicillin: a comparison of one-week and two-week treatments [abstract]. Gut 1995; 37 Suppl. 1: 91
40. Catalano F, Privitera U, Catanzaro R, et al. Omeprazole plus clarithromycin: efficacy of two treatment regimens on Helicobacter pylori positive duodenal ulcer [abstract]. Gut 1995; 37 Suppl. 1: 41
41. Schaufelberger H, Logan RPH, Misiewicz JJ, et al. The dosage & frequency of omeprazole are important in treating H. pylori with dual therapy [abstract]. Gastroenterology 1993; 104 (4, Part 2): A186
42. Chiba N, Wilkinson JM, Hunt RH. Clarithromycin (C) or amoxicillin (A) dual and triple therapies in H. pylori (Hp) eradication: a meta-analysis [abstract no. T124]. Gut 1995; 37 Suppl. 2: A31
43. Labenz J, Adamek RJ, Tillenburg B, et al. One-week treatment with omeprazole, amoxicillin and clarithromycin or metronidazole for cure of Helicobacter pylori infection [abstract]. Gut 1995; 37 Suppl. 1: 43
44. Lamouliatte H, Cayla R, Zerbib F, et al. Dual therapy (DT) versus triple therapy (TT) for Helicobacter pylori (H. pylori) eradication. Preliminary results of a randomized controlled trial [abstract]. Gastroenterology 1994 Apr; 106 Suppl.: 120
45. Lind T, Veldhuyzen van Zanten SJO, Unge P, et al. The MACH1 study : optimal one-week treatment for H. pylori defined? [abstract]. Gut 1995; 37 Suppl. 1: A4
46. Jonas C, De KE, Nyst JF, et al. Helicobacter pylori treatment: an evaluation of ten days omeprazole-bismuth-clarithromycin [abstract]. Gastroenterology 1993 Apr; 104 Suppl.: A112
47. Delchier JC, Elamine I, Goldfain D, et al. Comparison of omeprazole (OM) + amoxicillin (AM) versus OM + clarithromycin (CLA) in the eradication of Helicobacter pylori (Hp) - results from a randomized study involving 120 patients [abstract]. Gut 1995; 37 Suppl, 1: 55
48. Dal Bo N, Grasso GA, Pilotto A, et al. Clarithromycin for the cure of Helicobacter pylori infection [abstract]. Gut 1994; 35 Suppl. 5: 16
49. Goddard AF, Logan RPH, Tonge KA, et al. Eradication of Helicobacter pylori using clarithromycin, omeprazole and amoxycillin for one week [abstract]. Gut 1995; 37 Suppl. 1: 88
50. Grasso GA, Battaglia G, Germana B, et al. Efficacy of low doses of clarithromycin for one week in eradicating H. pylori [abstract no. 17]. Gut 1995; 37 Suppl. 1: A5
51. Neri M, Susi D, Laterza F, et al. Omeprazole, bismuth and clarithromycin in the sequential treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1994 Aug; 8: 469-71
52. Neves B, Vá S, Duarte C, et al. Eradicating H. pylori in peptic ulcer disease [abstract no. 396]. Am J Gastroenterol 1994; 89 (8): 1384
53. Chiba N. Low dose omeprazole (O) + clarithromycin (C) ± metronidazole (M) in the eradication of H. pylori (Hp): Interim results [abstract no. 328]. Am J Gastroenterol 1994 Aug: 1367
54. Forné M, Viver JM, Espinós JC, et al. Colloidal bismuth subcitrate is necessary in one week therapy with omeprazole and clarithromycin in the treatment of Helicobacter pylori associated duodenal ulcer: randomized study [abstract]. Gastroenterology 1994 Apr; 106 Suppl.: 77
55. Malfertheiner P. Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment. Scand J Gastroenterol 1993; 28 Suppl. 196: 34-7
56. Craft JC, Olson C, Siepman N, et al. Clarithromycin resistance in U.S. and European patients treated with clarithromycin (CL) and omeprazole (OM) for duodenal ulcer disease associated with H. pylori (HP) infection [abstract no. 103]. Am J Gastroenterol 1995; 90(9): 1579
57. Tillenburg B, Labenz J, Siehoff S, et al. The situation of primary resistance of Helicobacter pylori to commonly used antibiotics in Germany [abstract no. 163]. Am J Gastroenterol 1995; 90: 1594
58. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102 (2): 493-6
59. Schaufelberger H, Logan RPH, Baron JH. The effect of compliance on H. pylori eradication with dual therapy [abstract no. 21P]. Schweiz Med Wochenschr 1993; 123 (45) Suppl. 55: 22
60. Moayyedi P, Axon ATR. Patient factors that predict failure of omeprazole, clarithromycin and tinidazole (OCT) to eradicate Helicobacter pylori (H. pylori) [abstract]. Gut 1995; 36 Suppl. 1: 46
61. DeBartolo M, Reitmayer R, Olson C, et al. Effect of smoking on H. pylori (HP) eradication and duodenal ulcer (DU) recurrence in patients receiving dual therapy with clarithromycin (CL) in combination with omeprazole (OM). Gut 1995; 37 Suppl. 1: 85
62. Chew K, Eidus L. Clarithromycin and high dose omeprazole for Helicobacter pylori eradication: a comparison of one and two week therapy [abstract]. Gastroenterology 1994 Apr; 106 Suppl.: 62
63. Vakil N, Fennerty B. Decision analysis of the economic impact of H pylori eradication regimens. Gut 1995; 37 Suppl. 1: 56
64. Davey PG, Craig A-M, Murray F, et al. A decision analysis of healthcare costs following eradication of H. pylori with omeprazole in combination with either amoxycillin or clarithromycin [abstract]. Gut 1995; 37 Suppl. 1: 47
65. Olson C, DeBartolo M, Hippensteel R, et al. The safety of dual therapy with clarithromycin and omeprazole in the treatment of patients with duodenal ulcer disease associated with H. pylori infection [abstract]. Gut 1995; 37 Suppl. 1: 43
66. Olson C, DeBartolo M, Hippensteel R, et al. The safety of dual therapy with clarithromycin and omeprazole in the treatment of patients with duodenal ulcer disease associated with H. pylori infection. Abbott Park, Illinois, USA: Abbott Laboratories. (Data on file).
67. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease.. J Am Med Assoc 1994; 272: 65-9